These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7038199)

  • 21. Myeloproliferative diseases in childhood.
    Nix WL; Fernbach DJ
    Am J Pediatr Hematol Oncol; 1981; 3(4):397-407. PubMed ID: 6174053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Classification for myeloproliferative neoplasms and function of novel mutations].
    Kirito K
    Rinsho Ketsueki; 2011 Oct; 52(10):1575-84. PubMed ID: 21971234
    [No Abstract]   [Full Text] [Related]  

  • 23. Myelodysplastic and myeloproliferative disorders in children.
    Hasle H
    Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pelger-Huët congenital anomaly and acquired pelgerizations].
    Follana R; Muratore R
    Mars Med; 1972; 109(2):109-18. PubMed ID: 4502452
    [No Abstract]   [Full Text] [Related]  

  • 25. [Classification from FAB to WHO in myeloid malignancies].
    Watanabe R; Kizaki M
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():287-92. PubMed ID: 23133969
    [No Abstract]   [Full Text] [Related]  

  • 26. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Classification of chronic myeloproliferative diseases and their nomenclature].
    Demidova AV
    Gematol Transfuziol; 1983 Feb; 28(2):15-20. PubMed ID: 6341161
    [No Abstract]   [Full Text] [Related]  

  • 28. [bcr rearrangement in variant Ph1-positive chronic myelocytic leukemia and unclassified myeloproliferative disorders].
    Sekito N; Takahashi I
    Rinsho Ketsueki; 1988 Jul; 29(7):1018-24. PubMed ID: 3184469
    [No Abstract]   [Full Text] [Related]  

  • 29. CMML: a biologically distinct myeloproliferative disease.
    Cortes J
    Curr Hematol Rep; 2003 May; 2(3):202-8. PubMed ID: 12901341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of Philadelphia translocation-negative myeloproliferative neoplasms: its impact on data from clinical trials.
    Naresh KN
    J Clin Oncol; 2009 Nov; 27(31):e175-6; author reply e177-8. PubMed ID: 19704052
    [No Abstract]   [Full Text] [Related]  

  • 31. Philadelphia chromosome-negative chronic myeloproliferative disease.
    Thiele J
    Am J Clin Pathol; 2009 Aug; 132(2):261-80. PubMed ID: 19605821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The WHO classification of the myelodysplastic syndromes.
    Bain B
    Exp Oncol; 2004 Sep; 26(3):166-9. PubMed ID: 15494682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y
    Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
    [No Abstract]   [Full Text] [Related]  

  • 34. [Monosomy 7 in hematologic processes. Clinical and prognostic implications].
    Bello López JL; Viejo Llorente A; Gómez Vázquez MJ
    Sangre (Barc); 1984; 29(3):299-301. PubMed ID: 6484779
    [No Abstract]   [Full Text] [Related]  

  • 35. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia.
    Hyun BH; Gulati GL; Ashton JK
    Clin Lab Med; 1990 Dec; 10(4):825-38. PubMed ID: 2272176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Concept and classification of chronic myeloproliferative disorders].
    Jinnai I
    Nihon Naika Gakkai Zasshi; 2007 Jul; 96(7):1331-7. PubMed ID: 17682417
    [No Abstract]   [Full Text] [Related]  

  • 38. Myeloproliferative disorder of rats induced by myeloproliferative sarcoma virus.
    Itoyama S; Hayashi Y
    Keio J Med; 1987 Jan; 36(1):74-80. PubMed ID: 3475496
    [No Abstract]   [Full Text] [Related]  

  • 39. [Significance of hemopoietic dysplasia--from the initial suggestion of the term, hemopoietic dysplasia, to the organization of Internation Preleukemia Study Group].
    Kamata S
    Rinsho Ketsueki; 1979 Oct; 20(10):1247-50. PubMed ID: 44321
    [No Abstract]   [Full Text] [Related]  

  • 40. Myelodysplastic syndromes: is another classification necessary?
    Spitzer TR; Goldsmith GH
    Br J Haematol; 1982 Oct; 52(2):343-4. PubMed ID: 7126476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.